|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.16 CNY | -2.21% |
|
-0.29% | -15.05% |
| 07-02 | Tranche Update on Yifan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 27, 2026. | CI |
| 06-22 | Yifan Pharmaceutical Subsidiary Wins National Procurement Bid for Loquat Syrup | MT |
| Market Cap | 10.5B 1.55B 1.36B 1.26B 1.16B 2.19B 149B 2.21B 15.03B 5.88B 73.2B 5.82B 5.7B 253B | P/E 2026 * |
27.4x | P/E 2027 * | 22x |
|---|---|---|---|---|---|
| Enterprise Value | 10.5B 1.55B 1.36B 1.26B 1.16B 2.19B 149B 2.21B 15.03B 5.88B 73.2B 5.82B 5.7B 253B | EV / Sales 2026 * |
1.88x | EV / Sales 2027 * | 1.77x |
| Free-Float |
53.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.21% | ||
| 1 week | -0.29% | ||
| Current month | +8.66% | ||
| 1 month | +4.63% | ||
| 3 months | -14.77% | ||
| 6 months | -19.75% | ||
| Current year | -15.05% |
| 1 week | 10.05 |  | 11.05 |
| 1 month | 9.07 | | 11.05 |
| Current year | 9.07 | | 14.73 |
| 1 year | 9.07 | | 16.66 |
| 3 years | 9.07 | | 16.86 |
| 5 years | 9.07 | | 21.26 |
| 10 years | 8.68 | | 34.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Da Wei Zhang
DFI | Director of Finance/CFO | 45 | 09/07/2023 |
Xian Feng Cheng
PSD | President | 58 | 06/11/2014 |
Yan Bing Bai
CTO | Chief Tech/Sci/R&D Officer | 62 | 13/10/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Xian Feng Cheng
CHM | Chairman | 58 | 14/10/2014 |
Ben Yu Zhou
BRD | Director/Board Member | 53 | 14/10/2014 |
Xing Lin
BRD | Director/Board Member | 40 | 27/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/02/24 | Buy | Director | 33,300 | 0.0039% | ||
| 19/02/24 | Buy | Chief Financial Officer | 12,700 | 0.0015% | ||
| 19/02/24 | Buy | 9,100 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.21% | -0.29% | -29.49% | -27.27% | 1.56B | |
| -1.00% | +0.24% | +49.32% | +152.42% | 1,048B | |
| +1.62% | +2.85% | +51.30% | +48.51% | 603B | |
| +0.17% | +4.87% | +36.82% | +78.80% | 452B | |
| +0.16% | +1.36% | +31.72% | +22.38% | 327B | |
| -0.17% | +2.64% | +35.89% | +37.91% | 283B | |
| +1.72% | +0.97% | +22.57% | +17.70% | 259B | |
| -1.38% | -3.19% | -24.51% | -41.82% | 219B | |
| +0.96% | +2.85% | +20.56% | +56.55% | 198B | |
| +1.67% | +0.10% | +19.66% | +69.75% | 162B | |
| Average | +0.18% | +1.28% | +21.38% | +41.49% | 355.33B | |
| Weighted average by Cap. | +0.21% | +1.69% | +35.89% | +73.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.58B 825M 723M 670M 617M 1.16B 79.43B 1.18B 7.99B 3.13B 38.93B 3.1B 3.03B 134B | 5.92B 875M 767M 711M 654M 1.23B 84.27B 1.25B 8.48B 3.32B 41.3B 3.28B 3.21B 143B |
| Net income | 452M 66.75M 58.51M 54.21M 49.9M 94.09M 6.43B 95.23M 647M 253M 3.15B 251M 245M 10.88B | 564M 83.29M 73.01M 67.65M 62.26M 117M 8.02B 119M 807M 316M 3.93B 313M 306M 13.57B |
| Net Debt | - | - |
Employees
4,182
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | CN¥10.13 | -0.30% | 16,763,960 |
| 21/07/26 | CN¥10.16 | -2.21% | 21,497,922 |
| 20/07/26 | CN¥10.39 | +1.76% | 19,693,354 |
| 17/07/26 | CN¥10.21 | -6.76% | 32,056,681 |
| 16/07/26 | CN¥10.95 | +4.68% | 38,827,676 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.16CNY
Average target price
13.00CNY
Spread / Average Target
+27.95%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002019 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition